Nasdaq podd.
How much is Insulet stock worth today? ( NASDAQ: PODD) Insulet currently has 69,821,118 outstanding shares. With Insulet stock trading at $162.58 per share, the total value of Insulet stock (market capitalization) is $11.35B. Insulet stock was originally listed at a price of $15.96 in May 15, 2007.
Aug 31, 2023 · Fintel reports that on October 2, 2023, Jefferies upgraded their outlook for Insulet (NASDAQ:PODD) from Hold to Buy.. Analyst Price Forecast Suggests 81.05% Upside. As of August 31, 2023, the ... “Insulet Corporation (NASDAQ:PODD) is a medical device company focused on the design, development and commercialization of insulin pump systems for people with type 1 diabetes. Diabetes is a ...The price-to-earnings ratio for Insulet Corporation (NASDAQ: PODD) is above average at 92.44x. The 36-month beta value for PODD is also noteworthy at 0.87. There are mixed opinions on the stock, with 15 analysts rating it as a “buy,” 3 rating it as “overweight,” 6 rating it as “hold,” and 0 rating it as “sell.”.Our PODD ETF report shows the ETFs with the most PODD exposure, the top performing PODD ETFs, and most popular PODD ETF strategies ... First Trust Nasdaq Lux ...
INSULET CORPORATION ( PODD) is a large-cap growth stock in the Medical Equipment & Supplies industry. The rating using this strategy is 77% based on the firm’s underlying fundamentals and the ...Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to making the lives of people with ...Nov 21, 2023 · Insulet Corporation (NASDAQ: PODD)’s stock price has plunge by 4.14relation to previous closing price of 174.06. Nevertheless, the company has seen a 10.72% surge in its stock price over the last five trading sessions. Zacks Investment Research reported 2023-11-10 that Insulet (PODD) could produce exceptional returns because of its solid growth attributes. Is It Worth […]
On March 10, 2023, Insulet Corporation (NASDAQ:PODD) stock closed at $280.36 per share. One-month return of Insulet Corporation (NASDAQ:PODD) was -6.11%, and its shares gained 32.27% of their ...
The latest price target for . Insulet (NASDAQ: PODD) was reported by Piper Sandler on November 3, 2023.The analyst firm set a price target for $250.00 expecting PODD to rise to within 12 months (a ...Turning to the calls side of the option chain, the call contract at the $320.00 strike price has a current bid of $61.00. If an investor was to purchase shares of PODD stock at the current price ...Insulet Corporation (NASDAQ: PODD)’s stock price has plunge by 4.14relation to previous closing price of 174.06. Nevertheless, the company has seen a 10.72% surge in its stock price over the last five trading sessions. Zacks Investment Research reported 2023-11-10 that Insulet (PODD) could produce exceptional returns …Fintel. Fintel reports that on October 17, 2023, JP Morgan maintained coverage of Insulet (NASDAQ:PODD) with a Overweight recommendation. Analyst Price Forecast Suggests 109.29% Upside As of ...
Find the latest Insider Activity data for Insulet Corporation Common Stock (PODD) at Nasdaq.com.
Insulet, with stock symbol PODD, is a company originating in United States and listed on NASDAQ working in Health Care.
Nov 13, 2023 · Insulet (PODD) stock up 14% on positive earnings and growth forecast. Shares of medical device company Insulet Corporation (NASDAQ: PODD) witnessed a remarkable surge, jumping by 14% on Friday in response to the company's recent earnings report. The substantial increase... PODD Latest Pre Market Trades. Select time range to see more trades: Last 100 Trades. Pre-Market Time (ET) Pre-Market Price. Pre-Market Share Volume. 09:29:46. $231.39.Fintel reports that on October 17, 2023, JP Morgan maintained coverage of Insulet (NASDAQ:PODD) with a Overweight recommendation. Analyst Price Forecast Suggests 109.29% Upside As of October 5 ...The stock of Insulet ( NASDAQ:PODD) appears to be significantly undervalued based on GuruFocus' valuation method. With its current price of $230.76 per share and a market cap of $16.10 billion ...In the last profile of Insulet Corporation (NASDAQ:PODD) from July last year, the case was provided for the company to trade from $240 and sell at $284 over a 4–6 month period. PODD did reach ...PODD attempting to break out of it's steep earnings selloff NASDAQ:PODD I published yesterday that this stock has a long history of steep selloffs immediately followed by steep rebounds upward with multiple selloffs rebounding off of this same price level within the past 3 years. This could potentially be another of those rebounds. Written by Zacks Equity Research for Zacks ->. Insulet PODD is scheduled to report third-quarter 2023 results on Nov 1, after market close. In the last reported quarter, the company’s adjusted ...
INSULET CORPORATION ( PODD) is a large-cap growth stock in the Medical Equipment & Supplies industry. The rating using this strategy is 77% based on the firm’s underlying fundamentals and the ...Add symbols now or see the quotes that matter to you, anywhere on Nasdaq.com. Start browsing stocks, funds and ETFs, and more asset classes. Add/Edit Symbols Edit …Insulet stock (NASDAQ NDAQ: PODD) currently trades at $156 per share, about 29% lower than the level seen in early June 2022, just before the Fed started increasing rates, compared to 14% gains ...Insulet Corporation (NASDAQ:PODD) Hedge Fund Holdings: 44 . Based in Massachusetts, Insulet Corp. (NASDAQ:PODD) is an American diabetes device manufacturer which focuses on the production and ...Oct 30, 2023 · One-month return of Insulet Corporation (NASDAQ:PODD) was -20.57%, and its shares lost 49.35% of their value over the last 52 weeks. Insulet Corporation (NASDAQ:PODD) has a market capitalization ...
Fintel reports that on October 17, 2023, JP Morgan maintained coverage of Insulet (NASDAQ:PODD) with a Overweight recommendation. Analyst Price Forecast Suggests 109.29% Upside As of October 5 ...Insulet (NASDAQ: PODD), headquartered in Acton, Massachusetts, and with offices and manufacturing facilities around the world, is a global company with growing reach. We strive to bring our innovations to all who need them, wherever they are.
INSULET CORPORATION ( PODD) is a large-cap growth stock in the Medical Equipment & Supplies industry. The rating using this strategy is 77% based on the firm’s underlying fundamentals and the ...Insulet Corporation (NASDAQ:PODD) trade information. Sporting 3.82% in the green today, the stock has traded in the green over the last five days, with the highest price hit on Monday, 11/13/23 when the PODD stock price touched $169.96 or saw a rise of 2.8%.Insulet (PODD) stock up 14% on positive earnings and growth forecast. Shares of medical device company Insulet Corporation (NASDAQ: PODD) witnessed a remarkable surge, jumping by 14% on Friday in response to the company's recent earnings report. The substantial increase...PODD News Headlines · Orthofix (OFIX) Q3 Earnings Top Estimates, 2023 Sales View Cut · Labcorp (LH) Closes the Legacy Health Asset Acquisition Deal · Insulet ( ...NasdaqGS:PODD Discounted Cash Flow August 14th 2023 Important Assumptions . Now the most important inputs to a discounted cash flow are the discount rate, and of course, the actual cash flows. If you don't agree with these result, have a go at the calculation yourself and play with the assumptions.Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its ...26-Sept-2023 ... Insulet stock (NASDAQ NDAQ -0.3% : PODD) currently trades at $156 per share, about 29% lower than the level seen in early June 2022, just ...Insulet Corporation (PODD) is a leading medical device company that is dedicated to creating advanced insulin delivery systems for individuals with diabetes. Their flagship product is designed to ...Insulet Corporation (NASDAQ:PODD) Q3 2023 Earnings Call Transcript (Insider Monkey) 08:07AM Q3 2023 Insulet Corp Earnings Call (Thomson Reuters StreetEvents) Nov-02 ...The forecasts range from a low of 322.19 to a high of $414.75. The average price target represents an increase of 57.05% from its latest reported closing price of 229.69. See our leaderboard of ...
Fintel reports that on October 17, 2023, JP Morgan maintained coverage of Insulet (NASDAQ:PODD) with a Overweight recommendation. Analyst Price Forecast Suggests 109.29% Upside As of October 5 ...
PODD Insulet Corp NASDAQ 188.51 -0.41 -0.22% Opening 13:12 11/30 EST OPEN 188.80 PREV CLOSE 188.92 HIGH 190.29 LOW 185.73 VOLUME 276.05K TURNOVER 0 52 …
The latest price target for . Insulet (NASDAQ: PODD) was reported by Piper Sandler on Friday, November 3, 2023.The analyst firm set a price target for 250.00 expecting PODD to rise to within 12 ...PODD Real-Time Quotes. Nasdaq provides NLS Volume, Previous Close, Today's High & Low, and the 52 week High & Low. The intraday chart, the last-five real-time quotes and sales data. Real-time ...Then look at the Insulet Corporation (NASDAQ:PODD) share price. It's 737% higher than it was five yea Announcing: Insulet (NASDAQ:PODD) Stock Soared An Exciting 737% In The Last Five Years | NasdaqINSULET CORPORATION ( PODD) is a large-cap growth stock in the Medical Equipment & Supplies industry. The rating using this strategy is 77% based on the firm’s underlying fundamentals and the ...Records 1 - 18 of 23 ... Find the latest historical data for Insulet Corporation Common Stock (PODD) at Nasdaq.com.34 minutes ago · Within the last quarter, Insulet (NASDAQ:PODD) has observed the following analyst ratings: In the last 3 months, 8 analysts have offered 12-month price targets for Insulet. The company has an ... Industry Average ( 27) You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how PODD scored across 33 valuation, financial, forecast, …25-Sept-2023 ... Insulet stock (NASDAQ: PODD) currently trades at $156 per share, about 29% lower than the level seen in early June 2022, just before the Fed ...
Insulet Corporation PODD reported adjusted earnings per share (EPS) of 38 cents for second-quarter 2023, marking a significant improvement from the year-ago period’s adjusted net loss of 6 cents ...Aug 17, 2023 · In the last profile of Insulet Corporation (NASDAQ:PODD) from July last year, the case was provided for the company to trade from $240 and sell at $284 over a 4–6 month period. PODD did reach ... Insulet Corporation (NASDAQ:PODD) Q3 2023 Earnings Call Transcript (Insider Monkey) 08:07AM Q3 2023 Insulet Corp Earnings Call (Thomson Reuters StreetEvents) Nov-02-23 07:01PM Insulet Corp (PODD) Reports 27% Revenue Increase in Q3 2023 (GuruFocus.com) 05:30PM Insulet (PODD) Q3 Earnings: Taking a Look at Key Metrics …Sep. 20, 2022- Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced it has received CE marking under the European Medical Device Regulation for its Omnipod 5 Automated Insulin Delivery System (Omnipod 5) for individuals aged two …Instagram:https://instagram. parlay sports bettingwhere to buy corporate bonds onlinewhat is the best medical insurance in californiaatandt stock predictions Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously said that 'Volatility is far from synonymous with risk.'Turning to the calls side of the option chain, the call contract at the $180.00 strike price has a current bid of $34.30. If an investor was to purchase shares of PODD stock at the current price ... stock agco1979 silver dollar coin worth Fintel reports that on August 9, 2023, Citigroup maintained coverage of Insulet (NASDAQ:PODD) with a Neutral recommendation.. Analyst Price Forecast Suggests 57.05% Upside. As of August 2, 2023 ...Based on analysts offering 12 month price targets for PODD in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 . aegon n.v. stock Mar 18, 2023 · Insulet Corporation (PODD) is a leading medical device company that is dedicated to creating advanced insulin delivery systems for individuals with diabetes. Their flagship product is designed to ... Insulet Corporation PODD recently announced positive results from the first pivotal study for the Omnipod 5 Automated Insulin Delivery System. The finding of the study suggests that Omnipod 5 ...